Pioglitazone for the treatment of NASH in patients with prediabetes or type 2 diabetes mellitus

被引：10
|
作者：
Cusi, Kenneth [1 ]
机构：
[1] Univ Florida, Div Endocrinol Diabet & Metab, 1600 SW Archer Rd,Room H-2, Gainesville, FL 32610 USA
来源：
GUT | 2018年 / 67卷 / 07期
关键词：
FATTY LIVER-DISEASE;
D O I：
10.1136/gutjnl-2017-313958
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1371 / 1371
页数：1
相关论文
共 50 条
  • [31] Executive summary: Updates to the dietary treatment of prediabetes and type 2 diabetes mellitus
    Pascual Fuster, V
    Perez Perez, A.
    Carretero Gomez, J.
    Caixas Pedragos, A.
    Gomez-Huelgas, R.
    Perez-Martinez, P.
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2021, 33 (02): : 73 - 84
  • [32] Executive summary: Updates to the dietary treatment of prediabetes and type 2 diabetes mellitus
    Pascual Fuster, Vicente
    Perez Perez, Antonio
    Carretero Gomez, Juana
    Caixas Pedragos, Assumpta
    Gomez-Huelgas, Ricardo
    Perez-Martinez, Pablo
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2021, 68 (04): : 277 - 287
  • [33] Executive summary: Updates to the dietary treatment of prediabetes and type 2 diabetes mellitus
    Pascual Fustera, V
    Perez Perez, A.
    Carretero Gomez, J.
    Caixas Pedragos, A.
    Gomez-Huelgas, R.
    Perez-Martinez, P.
    REVISTA CLINICA ESPANOLA, 2021, 221 (03): : 169 - 179
  • [34] Pioglitazone for the treatment of type 2 diabetes
    Nabrdalik, Katarzyna
    Cichocka, Edyta
    Zywiec, Joanna
    Chodkowski, Artur
    Gumprecht, Janusz
    CLINICAL DIABETOLOGY, 2014, 3 (04): : 176 - 180
  • [35] The effects of pioglitazone and metformin on plasma visfatin levels in patients with treatment naive type 2 diabetes mellitus
    Erdem, Gokhan
    Dogru, Teoman
    Tasci, Ilker
    Bozoglu, Ergun
    Muhsiroglu, Ozlem
    Tapan, Serkan
    Ercin, Cemal Nuri
    Sonmez, Alper
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 82 (02) : 214 - 218
  • [36] Pioglitazone is an effective treatment for patients with post-stroke depression combined with type 2 diabetes mellitus
    Hu, Yaozhi
    Xing, Haiyan
    Dong, Xiaomeng
    Lu, Wenxian
    Xiao, Xinxing
    Gao, Lilin
    Cui, Minghu
    Chen, Jinbo
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 10 (03) : 1109 - 1114
  • [37] Safety and Efficacy of Long-Term Pioglitazone Treatment for Patients With Prediabetes or T2DM and NASH
    Cusi, Kenneth
    Orsak, Beverly
    Lomonaco, Romina
    Finch, Joan
    Ortiz-Lopez, Carolina
    Bril, Fernando
    Diaz, Norma
    Kaminski-Graham, Rose
    Darland, Celia
    Musi, Nicolas
    Webb, Amy
    Hardies, Jean
    Tio, Fermin
    DIABETES, 2013, 62 : A309 - A309
  • [38] Tolerability of pioglitazone compared to metformin in patients with Type 2 diabetes mellitus.
    Herz, M
    Tan, MH
    Pavo, I
    Melnichenko, GA
    Shoustov, SB
    Gyimesi, A
    Varkonyi, T
    Johns, D
    Schluchter, BJ
    Widel, M
    DIABETOLOGIA, 2002, 45 : A251 - A252
  • [39] Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus
    Irons, BK
    Greene, RS
    Mazzolini, TA
    Edwards, KL
    Sleeper, RB
    PHARMACOTHERAPY, 2006, 26 (02): : 168 - 181
  • [40] Effect of pioglitazone on serum concentrations of osteoprotegerin in patients with type 2 diabetes mellitus
    Park, Jong Suk
    Cho, Min Ho
    Nam, Ji Sun
    Yoo, Jeong Seon
    Ahn, Chul Woo
    Cha, Bong Soo
    Kim, Kyung Rae
    Lee, Hyun Chul
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2011, 164 (01) : 69 - 74
12345